CD8A and neoplasm: By pre-selecting, as PBMC donors, patients presenting a high circulating tumor burden, and, therefore, strongly impaired NK and CD8+ T cell repertoires, one can reasonably think that their immunodeficient profile was conserved by the engrafted mice.